The 400,000 Injection Insight: Japan’s Blueprint for the Future of HA Fillers

Introduction Hyaluronic acid (HA) fillers are among the most widely performed minimally invasive aesthetic procedures globally, with over 6.3 million procedures performed worldwide in 2023. While traditionally used for localized contouring, emerging large-scale data from Japan indicate a paradigm shift toward full-face, anatomy-based rejuvenation—particularly in aging populations.

The study by Taichi Tamura et al. (2026) provides one of the most comprehensive real-world datasets to date, offering insight into how clinical practice is evolving at scale.

Study Design and Scale This retrospective, multi-center analysis evaluated:

• 299,413 treatment sessions

• 417,590 individual injection sites

• Data from 110 clinics across Japan (2020–2024) 

Figure 1. Annual number of treatment sessions from 2020 to 2024. The total number of sessions increased steadily each year, reaching 117,577 in 2024. This growth was accompanied by a gradual demographic shift toward middle-aged and older individuals. Note: 2020 represents a partial year (October–December only). Key Epidemiological Trends

The observed increase to 117,577 annual treatment sessions (2024) and the near 3-fold rise in mean patients per clinic (391.7 → 1068.9) is not simply a reflection of market expansion—it reflects a multi-factorial shift in clinical demand, patient demographics, and treatment philosophy. A. Demographic Aging and Preventive Aesthetics Japan has one of the world’s most rapidly aging populations, with a growing proportion of patients in the ≥40 age group (63.7% in this dataset). This demographic shift directly correlates with:

• Increased prevalence of age-related volume loss, ligament laxity, and skeletal resorption

• Higher demand for non-surgical, maintenance-based rejuvenation strategies

Unlike younger patients seeking one-time contouring, older patients typically require:

• Repeat treatments

• Multi-area correction

• Longitudinal care plans

This converts HA fillers from a single intervention into a recurring therapeutic modality, driving volume growth. B. Shift from Augmentation to Rejuvenation Paradigm

Historically, HA fillers in Asia were used primarily for:

• Nose augmentation

• Chin projection

• Lip enhancement
  

However, the dataset shows a transition toward:

• Orbital rim / tear trough correction

• Mid-face volumization

• Nasolabial and lower face support
  

This reflects a broader adoption of:

• Structural volumization concepts

• Full-face assessment frameworks

Rejuvenation inherently requires more injection sites per session, increasing total procedural volume even if patient numbers remain constant. C. Increased Treatment Complexity and Multi-Site Protocols The rise in mean injection sites per session (1.32 → 1.50) is clinically significant. This indicates:

• Movement toward pan-facial correction

• Recognition that isolated correction can lead to disharmony or suboptimal outcomes
  

From a systems perspective:

• Each patient now consumes more treatment units (sites, syringes, time)

• This amplifies procedural volume without requiring proportional growth in new patients

Demand growth is therefore intensity-driven, not just volume-driven. D. Technological and Product Advancements Advancements in HA filler technology have contributed to increased adoption:

• Improved rheological profiles (G’, cohesivity) allowing:

  • Deep structural support (e.g., periosteal placement)

  • Superficial refinement with lower risk of irregularities

• Enhanced longevity and integration, reducing complication rates

• Availability of indication-specific fillers (e.g., for tear trough vs deep support)
  

These innovations increase physician confidence and treatment indications, expanding patient eligibility. E. Cultural Preference for Minimally Invasive, Natural Outcomes In Japan, there is a strong aesthetic preference for: Subtle, natural-looking enhancement

• Avoidance of “overfilled” or artificial appearance
  

HA fillers align well with this paradigm because they:

• Allow incremental correction

• Are reversible (hyaluronidase)

• Provide predictable outcomes with low downtime
  

Compared to surgical interventions, fillers offer a lower-risk entry point, broadening the patient base. F. Integration into Multimodal Treatment Ecosystems

Although this study isolates HA fillers, their increased use is closely linked to their role in combination therapy frameworks, including:

• PDO threads → lifting vectors

• Botulinum toxin → dynamic modulation

• Energy-based devices → skin tightening

In such protocols, HA fillers often serve as the foundational structural component.

As combination therapies expand, HA filler usage increases as part of bundled treatment plans, not just standalone procedures. Anatomical Shift in Injection Patterns The study demonstrates a clear age-dependent shift in injection targets, with younger patients (20s–30s) predominantly treated in areas such as pretarsal fullness (aegyo-sal) and chin augmentation, reflecting a focus on facial contouring and proportional enhancement rather than correction of aging changes. Anatomically, these interventions target structurally stable regions—augmenting the pretarsal space over the orbicularis oculi to create a youthful convexity, or enhancing chin projection via pre-periosteal filler placement to improve lower facial balance.

Figure 3. Proportion of specific injection sites within each age category. A clear age-dependent divergence in treatment goals is observed. Among patients in their teens and 20s, pretarsal fullness and chin augmentation were the most common procedures, reflecting a preference for contour enhancement. Conversely, in patients aged 50 and older, the orbital rim and nasolabial folds became predominant, while pretarsal fullness injections decreased to negligible levels, reflecting a shift toward rejuvenation. In this cohort, skin elasticity, fat compartment integrity, and ligamentous support remain largely preserved, allowing for localized, single-site treatments aimed at optimizing facial harmony rather than addressing volume loss or tissue descent. This contrasts with older populations, where injection patterns shift toward mid-face and periorbital rejuvenation, highlighting the importance of age-specific, anatomy-driven treatment strategies in designing effective and individualized aesthetic interventions. Why Japan Is Leading This Shift Japan’s leadership in multi-site, structural HA injection strategies is driven by demographic, anatomical, and cultural factors. First, Japan has a rapidly aging population, with patients aged 40 and older accounting for 63.7% of HA procedures in 2024, up from 39.4% in 2021 (Tamura et al., 2026). This demographic shift has created strong demand for rejuvenation-focused treatments rather than purely contouring procedures typical in younger cohorts. Older patients increasingly require multi-site injections to address volume loss, skeletal resorption, and ligament laxity, explaining the steady rise in average injection sites per session from 1.32 in 2021 to 1.50 in 2024.

Second, East Asian facial anatomy—including wider zygomas, midface retrusion, and relatively thick skin—creates unique aesthetic challenges. As the midface loses skeletal support and deep fat deflates, treatment strategies must go beyond single-site enhancement to restore structural volume and reposition soft tissue, a trend particularly evident in orbital rim, mid-cheek, and marionette line injections. Finally, cultural preferences for natural, subtle, and restorative results drive clinicians to adopt age- and anatomy-specific approaches, favoring multi-site structural rejuvenation over exaggerated augmentation. Together, these factors explain why Japan has become a global leader in evidence-based, integrated HA injection strategies tailored to both anatomical realities and patient expectations.

Picture source: Azabu Clinic Japan

Integrated, Evidence-Based Treatment Strategies Integrated, evidence-based treatment strategies mean treating the face as a whole, rather than focusing on a single wrinkle or area. Instead of just filling lines, clinicians address the underlying causes of aging—including bone loss, fat volume reduction, and tissue laxity—using a structured, anatomy-based approach.

In practice, this involves multi-site HA filler injections to restore facial balance, often combined with other treatments such as PDO threads for lifting, neuromodulators for muscle control, and devices for skin quality. This combination approach leads to more natural, balanced, and longer-lasting results compared to treating one area alone.

Overall, the goal is personalized treatment planning, where each patient’s age, anatomy, and degree of aging guide the strategy—resulting in safer, more effective, and more predictable outcomes.

Conclusion HA injections in Japan are shifting toward rejuvenation rather than simple contouring primarily due to an aging population, deeper understanding of facial aging as a structural process, and a strong cultural preference for natural, subtle outcomes. As patients age, concerns move beyond enhancement to restoring lost volume, support, and facial harmony—driving the need for multi-site, anatomy-based treatments instead of isolated corrections.

This shift matters because it reflects a broader evolution in aesthetic medicine toward evidence-based, integrated approaches. Clinicians are no longer treating visible lines alone but addressing the root causes of aging, leading to more predictable, balanced, and long-lasting results. For practitioners, this underscores the importance of full-face assessment and combination strategies; for patients, it highlights why modern treatments may involve multiple areas to achieve natural rejuvenation.

Ultimately, Japan’s data-driven transition serves as a global indicator of where aesthetic practice is heading—toward more precise, personalized, and structurally focused treatment paradigms.

Reference:

1. Tamura, T., Tamura, T., Okumura, K., & Teranishi, H. (2026). From contouring to rejuvenation: A nationwide big-data analysis of hyaluronic acid injection trends in Japan. Journal of Clinical Medicine, 15(2), 893. https://doi.org/10.3390/jcm15020893

---

Learn the techniques behind Japanese Tailored Aesthetic Injectables & Combination Therapies:

IFAAS Mini Fellowship (Observation)​

Japanese Tailored Aesthetic Injectables & Combination Therapies

16-17 June, 2026 - Tokyo, Japan  - [Register Now]

---

More Upcoming Global Events

Global Event Calendar